Related Experiment Videos
Ischemic heart disease: metabolic approaches to management
Daniel F Pauly1, Carl J Pepine
1University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida 32610, USA. paulydf@medicine.ufl.edu
Abstract:
The number of patients with coronary artery disease and its risk factors is increasing in Western nations. New treatments for these patients may soon include a class of agents known as the metabolic modulators. This group of agents consists of the partial fatty acid oxidation inhibitors trimetazidine and ranolazine, as well as dichloroacetate, which promotes carbohydrate utilization. Metabolic modulators also include the nutriceuticals L-carnitine and D-ribose. The available evidence regarding the benefits of each of these five agents is reviewed.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis III: Management
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Cardiomyopathy V: Interprofessional Care